Neuromodulation Speaker Series

 

Wednesday, April 3, 2024, at 12 noon Eastern:

Randolph J. Nudo, Ph.D., FAHA, FASNR, of University of Kansas

 

Register now!

This monthly Speaker Series will be presented via Zoom and aims to present innovative ideas and cutting-edge methods for clinicians and researchers. At each meeting, a speaker will present a topic or study relating to the improvement of rehabilitation techniques through the use of neuromodulation. Researchers and clinicians of all career stages (including students and fellows) who are interested in neuromodulation and novel rehabilitation techniques are invited. The attendees will have the opportunity to ask questions, exchange ideas and opinions, and develop informal discussions.

Register now!



Past Presentation Video Recordings

March 6, 2024: Stephen Bornheim, PT, Ph.D., of University of Liège

From the NC NM4R Speaker Series, featuring Stephen Bornheim, PT, Ph.D.: "Challenges from Transitioning from Research to Clinical Practice with tDCS," March 6, 2024, 12 noon Eastern

February 7, 2024: Elsa Fouragnan, Ph.D., of University of Plymouth, UK

From the NC NM4R Speaker Series, featuring Elsa Fouragnan, Ph.D.: "Inducing early phase neuroplasticity with low intensity focused ultrasound in humans," February 7, 2024, 12 noon Eastern

Inducing early phase neuroplasticity with low intensity focused ultrasound in humans - video coming soon!

January 2024: No session

December 6, 2023: Roy Hamilton, M.D., University of Pennsylvania

From the NC NM4R Speaker Series, featuring Roy Hamilton, M.D.: "Stimulating Conversations: Using Non-Invasive Neuromodulation to Understand And Rehabilitate the Language System in Aphasia," December 6, 2023, 12 noon Eastern

Stimulating Conversations: Using Non-Invasive Neuromodulation to Understand And Rehabilitate the Language System in Aphasia – video coming soon!

Dr. Roy Hamilton is a tenured Professor of Neurology at the University of Pennsylvania with secondary appointments in Physical Medicine and Rehabilitation and Psychiatry. Dr. Hamilton’s laboratory research employs noninvasive neuromodulation to characterize and remediate human cognition in neurological disorders. He directs the Laboratory for Cognition and Neural Stimulation (LCNS) and the Penn Brain Science, Translation, Innovation and Modulation Center (brainSTIM). Additionally, Dr. Hamilton been recognized nationally for his work in diversity, inclusion, and equity in neurology and academic medicine.

October 4, 2023: Genevieve Albouy, Ph.D., University of Utah

From the NC NM4R Speaker Series, featuring Genevieve Albouy, Ph.D.: "Modulating the Neurophysiological Processes Support Wake- and Sleep-Related Motor Memory Consolidation," October 4, 2023, 12 PM Eastern

Modulating the Neurophysiological Processes Supporting Wake- and Sleep-Related Motor Memory Consolidation – video coming soon!

September 6, 2023: Cristin Welle, Ph.D.

From the NC NM4R Speaker Series, featuring Cristin Welle, Ph.D. presenting "Vagus Nerve Stimulation to Drive Motor Learning and Myelin Repair," September 6, 2023

Vagus Nerve Stimulation to Drive Motor Learning and Myelin Repair – video coming soon!

Cristin Welle, Ph. D., is a systems neurophysiologist with expertise in the interaction between medical devices and the nervous system. She completed her Ph.D. in 2010 from the University of Pennsylvania, and then started the Neural Interfaces Program at the FDA Center for Devices and Radiological Health Office of Science and Engineering Labs. In 2016, she joined the faculty of Neurosurgery and Bioengineering at the University of Colorado. Dr. Welle’s BIOElectrics Lab investigates how neurological medical devices interact with the nervous system.

 

June 7, 2023: Inês Violante, Ph.D.

From the NC NM4R Speaker Series, featuring Inês Violante, Ph.D., "Non-Invasive Stimulation of the Human Hippocampus Using Temporal Interference Stimulation"

Non-Invasive Stimulation of the Human Hippocampus Using Temporal Interference Stimulation decorative graphic

Dr. Ines Violante is an Assistant Professor at the University of Surrey, UK, where she leads the NeuroModulation Lab. Dr Violante is interested in developing and applying tools capable of influencing brain function non-invasively to understand and modulate brain networks to impact behaviour. The lab uses a multidisciplinary approach ranging from computational models, imaging (fMRI, EEG), sensory and electrical stimulation.


May 3, 2023: Kevin Caulfield, Ph.D.

From the NC NM4R Speaker Series, featuring Kevin Caulfield: "Toward Personalized and Optimized Noninvasive Brain Stimulation for Transdiagnostic Applications," May 3, 2023, 12 PM Eastern

Toward Personalized and Optimized Noninvasive Brain Stimulation for Transdiagnostic Applications decorative graphic

 

April 5, 2023: George Wittenberg, M.D., Ph.D.

From the NC NM4R Speaker Series, featuring George Wittenberg, M.D., Ph.D., "TMS and MRI Determine a Cortical Area's Role and Connectivity as it Pertains to Motor Behavior," April 5, 2023, 12 pm EDT

MS and MRI Determine a Cortical Area's Role and Connectivity as it Pertains to Motor Behavior decorative graphic

George Wittenberg, M.D., Ph.D., has a tenured appointment as professor in the Department of Neurology pending and is a Neurologist/Researcher in the Veterans Affairs Pittsburgh Healthcare System, and is Director of the Laboratory for Research on Arm Function and Therapy (RAFT), one of the Rehab Neural Engineering Labs. Dr. Wittenberg’s overall goal is the restoration of voluntary movement after neurological injury and in neurological disorders. His ongoing research interests presently lie in using transcranial magnetic stimulation (TMS) and functional imaging to understand motor cortical reorganization following stroke and in designing and testing new methods for neurorehabilitation. He has been conducting clinical trials with robotic rehabilitation and continues to study the neural plasticity that underlies it. He is developing hybrid methods of combining TMS with robotic and virtual reality training, and multimodal physiological monitoring with feedback control of robotic assistance, to maximize the return of motor function after neurological injury by harnessing activity-dependent brain plasticity.

 

March 1, 2023: André Machado, M.D., Ph.D.

From the NC NM4R Speaker Series, featuring André Machado, M.D., Ph.D., "V-DBC for Post-Stroke Rehabilitation: A First-in-Man Translational Study," March 1, 2023, 12 noon ET

V-DBS for Post-Stroke Rehabilitation: A First-in-Man Translational Study decorative graphic


Andre Machado, M.D, Ph.D.
is the Chairman of the Neurological Institute and the Charles and Christine Carroll Family Endowed Chair in Functional Neurosurgery. Dr. Machado performs deep brain stimulation (DBS) surgery for patients with Parkinson’s disease, tremor, dystonia and obsessive-compulsive disorder as well as surgical procedures for patients with trigeminal neuralgia, intractable pain syndromes and spasticity. Dr. Machado is a Professor of Neurosurgery at the Cleveland Clinic Lerner College of Medicine and has Joint Appointments in the Departments of Neuroscience and Biomedical Engineering. Dr. Machado leads several deep brain stimulation and neuromodulation clinical trials as well as laboratory research. His research in deep brain stimulation for thalamic pain syndrome was awarded the National Institutes of Health Director’s New Innovator’s Award. His current research is aimed at developing novel treatments to promote rehabilitation after stroke and other acquired brain injuries and is funded by the NIH BRAIN initiative.

 

February 1, 2023: Jesse Dawson, M.D., BSc (Hons), MBChB (hons), FRCP, FESO

decorative graphic, no unique info

Vagus Nerve Stimulation for Post Stroke Recovery – Current Evidence and Next Steps decorative graphic

Jesse Dawson, M.D., is Professor of Stroke Medicine and Consultant Physician in the Queen Elizabeth University Hospital. His research portfolio includes prevention and rehabilitation clinical trials in stroke survivors. His main interest is in improving the long-term outcome after stroke. Dr. Dawson holds a BHF/Stroke Association programme grant, HTA NIHR funding and NIH funding; runs a large outcomes adjudication system for multi-national stroke trials; is NHS Research Scotland lead for stroke research; and sits on the editorial board of Stroke.

 

December 7, 2022: Flavio Frohlich, Ph.D.

decorative graphic, no unique info

Fifteen Years of Entraining Brain Oscillations with Transcranial Alternating Current Stimulation: Past, Present, Future decorative graphic

Dr. Frohlich’s goal is to revolutionize how we treat psychiatric illnesses. His vision is that understanding brain network activity will enable the development of novel diagnosis and treatment paradigms. Flavio is convinced that such rational design of neurotherapeutics will open the door for individualized, highly effective brain stimulation in psychiatry. He is passionate about combining different methodological approaches to scientific problems and is a pioneer in the field of network neuroscience. His research integrates neurobiology, engineering, and medicine. The Frohlich Lab performs computer modeling combines electrophysiology, imaging, brain stimulation, and behavioral assays in animal models; records and modulates human brain activity; and studies new treatments in randomized controlled clinical trials. Flavio is also the director of the Carolina Center for Neurostimulation, which integrates brain stimulation research and clinical care.

 

October 5, 2022: Dan Iosifescu, M.D.

decorative graphic, no unique info

Transcranial Photobioneuromodulation with Near Infrared Light for Depression and Cognition decorative graphic

Dan Iosifescu, M.D., is the Director of Clinical Research at the Nathan Kline Institute and Associate Professor of Psychiatry at the New York University School of Medicine. His research is focused on novel pharmacological treatments (such as ketamine and other glutamatergic drugs) and devices (such as novel forms of magnetic stimulation) for patients with severe mood disorders (major depression and bipolar disorder). In his research, Dr. Iosifescu uses neuroimaging (MRI, MRS) and neurophysiology (quantitative EEG) techniques to evaluate structural, biochemical, and functional brain abnormalities in mood disorders and their impact on clinical treatment. In parallel, Dr. Iosifescu also focuses on the recognition and treatment of cognitive deficits associated with mood disorders.

 

August 3, 2022:  Michael Urbin, Ph.D.

decorative graphic, no unique info

Targeting a Mechanism of Dysfunction in the Spinal Cord to Address Motor Deficits after Stroke decorative graphic

Mike Urbin, Ph.D., is a Scientist with the U.S. Department of Veterans Affairs. He is jointly affiliated with the Rehabilitation Neural Engineering Laboratories at the University of Pittsburgh and the Human Engineering Research Laboratories within the VA Pittsburgh Healthcare System. Dr. Urbin’s primary research interest is in human motor control and learning. He uses a variety of noninvasive stimulation and structural imaging methods to study pathophysiology of stroke and spinal cord injury. A broad goal of his current research agenda is to understand mechanisms of motor dysfunction and how neuromodulation can be used to retrain distal limb muscles weakened by neurological injury.

 

July 6, 2022: Joel Voss, Ph.D.

decorative graphic

Enhancing Episodic Memory Networks with Noninvasive Brain Stimulation

Video not available due to recording error

Joel Voss, Ph.D., is an Adjunct Associate Professor of Medical Social Sciences at Northwestern University Feinberg School of Medicine.  The Voss laboratory uses human neuroscience methods (fMRI, EEG, TMS, eye tracking) to investigate mechanisms of learning and memory and their impairment in neurologic and neuropsychiatric disorders. They also use noninvasive stimulation methods to modulate distributed networks of the human hippocampus in order to test their roles in memory and to develop novel treatments for memory impairment.

 

June 1, 2022: Teresa Kimberley, Ph.D., PT

decorative graphic, no unique info

Paired Neuromodulation with Rehabilitation:  Lessons from Vagus Nerve Stimulation in Stroke decorative graphic

Teresa Jacobson Kimberley, PhD, PT, FAPTA is Professor and Director of the Brain Recovery Lab, in the Department of Physical Therapy in the School of Health and Rehabilitation Sciences at the MGH Institute. Her lab's focus is to understand the pathophysiology of motor impairment and develop novel rehabilitation interventions for neurologic disorders, such as dystonia and stroke. She has an appointment as Research Staff at Massachusetts General Hospital (MGH) Department of Neurology, and as Core Faculty in the Center for Neurotechnology and Neurorecovery. Her research helped to pioneer the use of neuroimaging and non-invasive brain stimulation in the investigation of rehabilitation-related areas. Her work is funded through the National Institutes of Health, private foundations and industry partners. She serves on the Foundation for Physical Therapy Scientific Review Committee, is an Associate Editor for the Journal of Neurologic Physical Therapy and Restorative Neurology and Neuroscience, and is on the editorial board of the Physical Therapy Journal.

 

May 4, 2022: Zhi-De Deng, Ph.D.

decorative graphic

Model-Driven Design for Brain Stimulation Therapies decorative graphic

Dr. Zhi-De Deng is a Staff Scientist, Director of the Computational Neurostimulation Research Program, Noninvasive Neuromodulation Unit, at the National Institute of Mental Health. He is also Adjunct Assistant Professor of Psychiatry & Behavioral Sciences, Duke University School of Medicine. He received the SB degree in physics, SB and MEng in electrical engineering and computer science, from MIT. He received PhD in electrical engineering from Columbia University. He completed postdoctoral training at Duke and research fellowship at NIMH. His research focuses on computational approaches 1) to understand the physics and biophysics of neurostimulation, 2) to optimize dosing and individualization, and 3) to advance noninvasive brain stimulation technology development via model-informed design. His vision is to transform psychiatry through engineering innovation.

 

April 6, 2022: Til Ole Bergmann, Ph.D., and Umair Hassan

promotional graphic

The BEST Toolbox: Increasing Objectivity, Reliability, and Reproducibility in Non-invasive Brain Stimulation Research decorative graphic

 

Developed by Mr. Hassan working in Dr. Bergmann’s lab, the BEST Toolbox is easy-to-use MATLAB-based open-source software with a powerful graphical user interface, which allows the user to flexibly design, run, analyze, and share multi-protocol/multi-session non-invasive brain stimulation studies, involving transcranial magnetic, electric, and ultrasound stimulation in combination with EMG, EEG, and fMRI.

 

 

March 2, 2022: Aiko Thompson, Ph.D.

decorative graphic

Operant Conditioning of Evoked EMG Responses for Enhancing Neurorehabilitation decorative graphic

A faculty member of NC NM4R, Aiko Thompson, Ph.D., has been investigating neurorehabilitation for over a decade. Dr. Thompson was the first researcher to implement the principles of Operant Conditioning for neural recovery on humans, and is the head of The Barbara S. Christie Evoked Potential Operant Conditioning (EPOC) laboratory and NC NM4R EPOC Core. She has won several NIH R01 grants, and will continue her research working with various populations to seek innovative approach for rehabilitation.

 

February 2, 2022: Simon Davis, Ph.D.

Simon Davis

Modulating Memory Network Dynamics in Healthy & Pathological Aging decorative graphic

Our understanding of the cortical mechanisms that contribute to healthy cognition as we age is an exciting and nascent domain of knowledge. Such an understanding of such patterns in healthy aging is a precondition to the effective treatment of age-related disorders like Alzheimer's disease. For example, the notion that older adults rely on a more bilateral system of brain regions (relative to younger adults) to maintain cognitive function has become generally well accepted. Nonetheless, the compensatory role of bilateral activation remains controversial because most of the data supporting this idea is correlational, and fails to actively engage these bilateral networks. Understanding the importance and malleability of such cross-hemispheric communication in cognition will likely provide a clear path for developing novel therapies to ameliorate age-related cognitive decline. In this talk I will present neuroimaging, neurophysiology, behavioral and TMS data that highlights this and other age-related mechanisms by which older adults may continue to perform tasks successfully, and how these mechanisms may be encouraged by noninvasive neuromodulation.

Dr. Simon Davis is an Assistant Professor in the Department of Neurology at Duke University, as well as the co-Director of Duke Brain Stimulation Research Center and the Director of the Neuroimaging Core: Bryan Alzheimer’s Disease Research Center. His research includes age-related reorganization during episodic memory, executive functions, and semantic processes, cross-hemispheric communication during episodic and semantic memory in younger and older adults, myelination in the aging brain, and its role in cognitive decline and connectivity during episodic memory processes using neuromodulation.

 

December 1, 2021: Bashar Badran, Ph.D.

decorative

Developing Novel Therapeutics – Focused Ultrasound and Auricular Neuromodulation as Alternatives to Implantable Brain Stimulation decorative graphic

Dr. Bashar Badran is a Neuroscientist and Assistant Professor of Psychiatry within the Brain Stimulation Division at the Medical University of South Carolina. Dr. Badran’s Neuro-X lab is a multidisciplinary neuromodulation, engineering, and innovation laboratory that fosters an environment of neurotechnology and innovation to begin addressing complex medical and neuropsychiatric disorders. His lab has been on the forefront of pioneering noninvasive vagus nerve stimulation and low transcranial focused ultrasound. Dr. Badran is also an inventor and co-founder of several startups, including Zendo, a neuromodulation device for meditation enhancement, and BabyStrong, a new feeding system for newborns.